Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-15

Clinical Trial Update: Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru [NA]

View source ↗

Summary

The NIAID-sponsored study completed a feasibility assessment for measuring immune activation in foreskin/mucosal tissue among HIV-negative, uncircumcised men wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | NA | Status: COMPLETED